Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com Prev Post Multiple New Multi-Commodity Targets May 12, 2025 Next Post Walgreens doubles down on prescription-filling robots to cut costs, free up pharmacists amid turnaround May 13, 2025 Related Posts SAGA Metals Completes Strategic Infrastructure Upgrades in Preparation for Major Drill Program at the 100% Owned Radar Titanium Property in Labrador, Canada July 31, 2025 Crypto Market Update: Markets Pull Back After Fed Opts to Keep Current Interest Rate July 31, 2025 Homerun Resources Inc. Appoints Strand Hanson Limited as UK Financial Adviser to Explore Dual Listing on London Stock Exchange July 31, 2025
SAGA Metals Completes Strategic Infrastructure Upgrades in Preparation for Major Drill Program at the 100% Owned Radar Titanium Property in Labrador, Canada July 31, 2025
Homerun Resources Inc. Appoints Strand Hanson Limited as UK Financial Adviser to Explore Dual Listing on London Stock Exchange July 31, 2025